PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,414 | +11.2% | 176,920 | +59.1% | 0.00% | – |
| Q2 2023 | $104,673 | -59.7% | 111,201 | -59.0% | 0.00% | – |
| Q1 2023 | $259,702 | +403.7% | 271,172 | +625.7% | 0.00% | – |
| Q4 2022 | $51,563 | -91.8% | 37,365 | -92.6% | 0.00% | – |
| Q3 2022 | $629,000 | -74.6% | 502,454 | -52.2% | 0.00% | – |
| Q2 2022 | $2,479,000 | +20.5% | 1,050,967 | +58.4% | 0.00% | – |
| Q1 2022 | $2,057,000 | -79.1% | 663,418 | -57.3% | 0.00% | -100.0% |
| Q4 2021 | $9,856,000 | -13.5% | 1,552,104 | +35.7% | 0.00% | -50.0% |
| Q3 2021 | $11,389,000 | -25.0% | 1,143,442 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $15,177,000 | +43.3% | 1,146,346 | +89.2% | 0.00% | 0.0% |
| Q1 2021 | $10,589,000 | -2.4% | 605,800 | +42.8% | 0.00% | 0.0% |
| Q4 2020 | $10,851,000 | +102.1% | 424,348 | +3.6% | 0.00% | +100.0% |
| Q3 2020 | $5,369,000 | -49.9% | 409,574 | +4.4% | 0.00% | -50.0% |
| Q2 2020 | $10,719,000 | +132.6% | 392,158 | +34.0% | 0.00% | +100.0% |
| Q1 2020 | $4,609,000 | – | 292,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |